100 related articles for article (PubMed ID: 9406240)
1. DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis.
Rauth AM; Goldberg Z; Misra V
Oncol Res; 1997; 9(6-7):339-49. PubMed ID: 9406240
[TBL] [Abstract][Full Text] [Related]
2. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
4. Suggested mechanism for the modulation of the activity of NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by menadione: interpretation of the effect of menadione on 5'-[p-(Fluorosulfonyl)benzoyl]adenosine labeling of rat liver NAD(P)H:quinone acceptor oxidoreductase.
Chen S; Liu XF
Mol Pharmacol; 1992 Sep; 42(3):545-48. PubMed ID: 1406605
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model.
Wu K; Eng E; Knox R; Chen S
Arch Biochem Biophys; 2001 Jan; 385(1):203-8. PubMed ID: 11361019
[TBL] [Abstract][Full Text] [Related]
6. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.
Begleiter A; Leith MK; Curphey TJ; Doherty GP
Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243
[TBL] [Abstract][Full Text] [Related]
7. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
8. Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine.
Liu XF; Yuan H; Haniu M; Iyanagi T; Shively JE; Chen SA
Mol Pharmacol; 1989 Jun; 35(6):818-22. PubMed ID: 2499768
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics.
Ross D; Siegel D
Methods Enzymol; 2004; 382():115-44. PubMed ID: 15047100
[No Abstract] [Full Text] [Related]
10. Increased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells.
Schlager JJ; Hoerl BJ; Riebow J; Scott DP; Gasdaska P; Scott RE; Powis G
Cancer Res; 1993 Mar; 53(6):1338-42. PubMed ID: 8443814
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
Cavelier G; Amzel LM
Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking is a determinant of DT-diaphorase gene expression in human non-small cell lung carcinoma.
Gasdaska PY; Powis G; Hyman P; Fisher H
Cancer Res; 1993 Nov; 53(22):5458-61. PubMed ID: 8221686
[TBL] [Abstract][Full Text] [Related]
13. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.
Yoshida T; Tsuda H
Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784
[TBL] [Abstract][Full Text] [Related]
14. Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state.
Mohora M
Rom J Intern Med; 2000-2001; 38-39():33-50. PubMed ID: 15529570
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase.
Graumann R; Paris I; Martinez-Alvarado P; Rumanque P; Perez-Pastene C; Cardenas SP; Marin P; Diaz-Grez F; Caviedes R; Caviedes P; Segura-Aguilar J
Pol J Pharmacol; 2002; 54(6):573-9. PubMed ID: 12866711
[TBL] [Abstract][Full Text] [Related]
16. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D
Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity.
Misra V; Grondin A; Klamut HJ; Rauth AM
Br J Cancer; 2000 Oct; 83(8):998-1002. PubMed ID: 10993645
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.
Workman P
Oncol Res; 1994; 6(10-11):461-75. PubMed ID: 7620214
[TBL] [Abstract][Full Text] [Related]
19. In vivo exposure of Dreissena polymorpha mussels to the quinones menadione and lawsone: menadione is more toxic to mussels than lawsone.
Osman AM; Rotteveel S; den Besten PJ; van Noort PC
J Appl Toxicol; 2004; 24(2):135-41. PubMed ID: 15052609
[TBL] [Abstract][Full Text] [Related]
20. Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors.
Li D; Gan Y; Wientjes MG; Badalament RA; Au JL
J Urol; 2001 Dec; 166(6):2500-5. PubMed ID: 11696818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
